Newsletter
0
Project CBD Newsletter: Psychedelic Shop Violence in Canada, Ayahuasca and Death Anxiety, Silicon Valley’s Grip on Psychedelic Medicine, and Ketamine Therapy for First Responders
0

This week’s newsletter covers psychedelic turf wars erupting in Toronto’s grey market, ketamine therapy concerns among law enforcement, ayahuasca’s ...

0
Project CBD Newsletter: CBD’s Potential as a Therapeutic Treatment for Cancer Patients, Hemp Regulation Updates, and Cannabinoid Research Round-Up
0

This week’s newsletter covers promising new research on CBD’s therapeutic potential for cancer patients, quality control concerns with commercial ...

0
Project CBD Newsletter: THC-Rich Extracts and Cancer Survival, CBD for Skin Conditions, Alzheimer’s Microdosing, and Ketamine Depression Trial Results
0

This week’s plant medicine newsletter covers THC-rich cannabis extracts and long-term cancer survival, CBD’s potential for skin conditions and ...

0
Project CBD Newsletter: Hemp Flour in Bread, Myrcene for Brain Injury, Cannabinoid Biosynthesis via Fungi, CBD/THC for Neuropathy, and CBD/THCV for Colitis
0

This week’s newsletter covers the latest plant medicine research, including hemp flour’s nutritional benefits in baking, myrcene’s neuroprotective ...

0
Project CBD Newsletter: Older Cannabis Users Show Superior Cognitive Performance, Industry Reacts to Federal Hemp THC Ban, and the Linguistic Evolution of Cannabis Culture
0

This week’s newsletter covers surprising findings on cannabis use and cognitive performance in older adults, the industry and policy fallout from the ...

0
Project CBD Newsletter: New seed ban risks driving cannabis genetics underground, terpenes activate cannabinoid receptors, psychedelics and capitalism, mushroom edible safety concerns, and cannabinoids for skin and prostate cancer
0

This week’s newsletter covers a federal cannabis seed ban threatening to push genetics underground, the science of terpenes activating cannabinoid ...

0
Project CBD Newsletter: Trump Signs Executive Order to Reclassify Cannabis as Schedule III, Hemp Enforcement Challenges, Cannabinoids and Ovarian Cancer, Sleep Research, and More
0

This week’s newsletter covers Trump’s executive order directing cannabis rescheduling to Schedule III, federal enforcement challenges around ...

0
Project CBD Newsletter: Trump Signs Order to Reclassify Cannabis as Schedule III, FDA/DEA Hemp Enforcement Challenges, Microdosing THC and CBD for Alzheimer’s, and More
0

This week’s newsletter covers cannabis rescheduling, hemp regulation enforcement hurdles, promising cannabinoid research for Alzheimer’s disease and ...

0
Project CBD Newsletter: Cannabis Rescheduling Uncertainty, Psychedelic Polypharmacy, Psilocybin and Fear Extinction, Ontological Shock, and Cancer-Related Depression
0

This week’s newsletter covers the uncertain fate of cannabis rescheduling under the Trump administration, along with new research on psychedelic ...

0
Project CBD Newsletter: How Psychedelics Inspire Scientific Insight, CBD Research on Pain, Inflammation, Alzheimer’s, Cancer, and Heart Disease
0

This week’s newsletter explores how psychedelic experiences can fuel scientific breakthroughs, alongside a roundup of recent research on CBD’s ...

Daily Deals
Logo
Compare items
  • Total (0)
Compare
0
Shopping cart